I have a PI who is applying for a grant in which he'll be working with yeast
DNA.  Because he is technically using recombinant DNA, though a
non-hazardous fungus, we are required to show that the proposal has been
reviewed by our Institutional Biosafety Committee.  Does anyone know where
in the NIH Guidelines for Research Involving Recombinant DNA Molecules it
deals with these non-hazardous, non-animal recombinant DNA molecules?  Or
has anyone had a similar experience that would shed some light on our
responsibilities in this case?
Thanks,
Amy Hibbard

"All power corrupts, but we need the electricity."

Amy Hibbard
Grants Administrator
Keck Graduate Institute of Applied Life Sciences
535 Watson Drive, Claremont, CA 91711
T: (909) 607-9313 / 607-7855
F: (909) 607-8086
xxxxxx@kgi.edu
www.kgi.edu

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================